GGrantIndex
← Leaderboards

Dennis M. McNamara

University Of Pittsburgh At Pittsburgh

$9,751,044
Attributed
$9,751,044
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $889.5K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,751,044 · 6

By mechanism

R01$3,776,328 · 2
UH3$3,039,242 · 1
K24$1,407,799 · 1
RC1$999,818 · 1
UG3$527,857 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Echocardiography

Research focus

EchocardiographyLeft Ventricular Ejection FractionHeart FailureCohortLeft Ventricular FunctionAmericanEnrollmentGenetic PolymorphismGeneticPathogenesisDisease-Free SurvivalInvestigationGenotypeVariantResponseBaseClinical ResearchRecoveryVariation (Genetics)EvaluationMedicalLeftMyocardialHaplotypes

Grant awards (27)

(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)$677,240
UH3 · FY2025 · HL · contact PI
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)$727,524
UH3 · FY2024 · HL · contact PI
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)$744,936
UH3 · FY2023 · HL · contact PI
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)$889,542
UH3 · FY2022 · HL · contact PI
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)$527,857
UG3 · FY2021 · HL · contact PI
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America$385,754
R01 · FY2018 · MD · contact PI
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America$385,213
R01 · FY2017 · MD · contact PI
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America$392,563
R01 · FY2016 · MD · contact PI
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America$395,039
R01 · FY2015 · MD · contact PI
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America$407,980
R01 · FY2014 · MD · contact PI
Racial Genomic Differences and Heart Failure Outcomes$161,032
K24 · FY2013 · HL · contact PI
Racial Genomic Differences and Heart Failure Outcomes$161,032
K24 · FY2012 · HL · contact PI
Racial Genomic Differences and Heart Failure Outcomes$161,032
K24 · FY2011 · HL · contact PI
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy$499,818
RC1 · FY2010 · HL · contact PI
Racial Genomic Differences and Heart Failure Outcomes$157,129
K24 · FY2010 · HL · contact PI
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy$500,000
RC1 · FY2009 · HL · contact PI
Racial Genomic Differences and Heart Failure Outcomes$153,338
K24 · FY2009 · HL · contact PI
Genetic Modulation of Left Ventricular Recovery$352,012
R01 · FY2008 · HL · contact PI
Genetic Modulation of Left Ventricular Recovery$352,012
R01 · FY2007 · HL · contact PI
Genetic Modulation of Left Ventricular Recovery$362,526
R01 · FY2006 · HL · contact PI
Cytokines and LV Recovery in Recent Onset Cardiomyopathy$128,596
K24 · FY2006 · HL · contact PI
Genetic Modulation of Left Ventricular Recovery$371,250
R01 · FY2005 · HL
Cytokines and LV Recovery in Recent Onset Cardiomyopathy$125,636
K24 · FY2005 · HL
Genetic Modulation of Left Ventricular Recovery$371,979
R01 · FY2004 · HL
Cytokines and LV Recovery in Recent Onset Cardiomyopathy$122,764
K24 · FY2004 · HL
Cytokines and LV Recovery in Recent Onset Cardiomyopathy$119,974
K24 · FY2003 · HL
Cytokines and LV Recovery in Recent Onset Cardiomyopathy$117,266
K24 · FY2002 · HL